Skip to content
Clinical Trials – home
Medical University Of Graz
Sponsor

Medical University Of Graz

Austria Neue Stiftingtalstrasse 6, 8010 Graz, Austria

About the sponsor

Research activity includes acute myocardial infarction, ST-elevation myocardial infarction, left ventricular thrombosis, and hypertrophic cardiomyopathy, with additional interest in reducing recurrent cardiovascular risk and managing arterial hypertension in complex cardiac disease.

  • Thrombus resolution after myocardial infarction
  • Cardiovascular risk factor management
  • Hypertrophic obstructive cardiomyopathy

The sponsor also supports studies in ischemic stroke linked to large artery occlusion and carotid disease, reflecting a broader interest in vascular and cerebrovascular care.

About Specializations

Medical University Of Graz runs clinical trials in conditions such as Neovascular age-related macular degeneration, Acute myocardial infarction, Type 1 diabetes mellitus, Arteriosclerosis coronary artery, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

22 clinical trials

Study on Managing Heart Attack Risk with Icosapent Ethyl and Drug Combination for Patients at High Risk of Another Heart Attack

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Colchicine
  • Sponsor:Medical University Of Graz
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Sponsor:Medical University Of Graz

Triple vs dual therapy with rosuvastatin, ezetimibe and bempedoic acid in patients with atherosclerotic heart disease and high cholesterol undergoing revascularisation

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Bempedoic Acid
  • Sponsor:Medical University Of Graz

High-Dose Colecalciferol for 28-Day Mortality in Critically Ill Adults with Severe Vitamin D Deficiency

Registered drug
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Colecalciferol
  • Sponsor:Medical University Of Graz

Skin wound

Recruiting

Study of the effect of hyperbaric oxygen therapy on the bacteria in chronic wounds

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Oxygen
  • Sponsor:Medical University Of Graz

Study of two initial doses of aflibercept for patients with newly diagnosed neovascular age-related macular degeneration

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Aflibercept
  • Sponsor:Medical University Of Graz

Comparing hydrochlorothiazide and valsartan for treating high blood pressure in patients with hypertrophic obstructive cardiomyopathy

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Hydrochlorothiazide
  • Sponsor:Medical University Of Graz

Comparing 1-Minute and 5-Minute Poractant Alfa Treatment for Respiratory Distress Syndrome in Very Premature Babies Born Before 28 Weeks

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:0–17 years
  • Substances:Poractant Alfa
  • Sponsor:Medical University Of Graz

Cataract+1

Recruiting

Study of herbal medicine combination and bromazepam for anxiety and pain in patients having eye surgery with retrobulbar anesthesia

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:LUPULI FLOS dry alcoholic extract
  • Sponsor:Medical University Of Graz

Study of cangrelor and acetylsalicylic acid in patients with ischemic stroke requiring emergency carotid artery stenting and mechanical thrombectomy

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Medical University Of Graz

Systemic candida+1

Recruiting

Study on Rezafungin Levels in Critically Ill Patients with Invasive Candidiasis Undergoing ECMO or RRT

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Rezafungin Acetate
  • Sponsor:Medical University Of Graz

Hypoxia+2

Recruiting

Oxygen Therapy to Prevent Breathing Problems After Non-Cardiac Surgery in Patients at Risk for Postoperative Complications

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:65+ years
  • Substances:Oxygen
  • Sponsor:Medical University Of Graz

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.